More than 30,000 cancer specialists from around the world will gather at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest innovations in research, quality, practice and technology in cancer.
More than 30,000 cancer specialists from around the world will gather at the 2011 American Society of Clinical Oncology (ASCO) Annual Meeting to discuss the latest innovations in research, quality, practice and technology in cancer.
The meeting will be held June 3-7, 2011 at McCormick Place located in Chicago, Illinois. This meeting will be the platform for the release of thousands of scientific abstracts — highly anticipated research news for many people, including patients, caregivers, and the general public. Today, many of those abstracts were made publicly available online (see below).
The 2011 Annual Meeting will center on a theme of “Patients, Pathways, Progress.” The theme, which was selected by ASCO President George W. Sledge, Jr., M.D., promises to:
- Represent “patients first,” said Dr. Sledge. “Everything we do as a Society has, as its eventual goal, the reduction of cancer mortality and morbidity. We’re on the front line in the war against cancer.”
- Focus on the molecular, clinical and research pathways that are used to find, develop and implement new treatments for people living with cancer.
- Celebrate the progress that has already been made in the treatment of cancer, while also reaffirming ASCO’s commitment to aggressive advancements in cancer research in the future.
- Easy-to-read summaries that put the top scientific news into context for patients.
- Videos and podcasts of national and international cancer experts, breaking down the science into specific disease areas and explaining what the studies mean for people with cancer.
- A news archive from previous ASCO Annual Meetings, which is searchable by year or disease type.
To receive ASCO Annual Meeting breaking news via email, you can sign up now to receive special editions of the newsletter Inside Cancer.Net. You can also follow Cancer.Net on Facebook or Twitter, where real-time updates will also be posted.
Medical abstracts from this year’s meeting were released today at 6:00 P.M. EDT/3:00 P.M. PDT, and additional studies will be released each day of the event in June.
The abstract categories released today, which may be of interest to an ovarian cancer survivor, include the following:
Cancer Prevention/Epidemiology
Developmental Therapeutics – Clinical Pharmacology and Immunotherapy
- Clinical Trial Design
- Cytotoxic Agents
- Immunotherapy and Biologic Therapy
- Nanotechnology
- Other
- Pharmacology
- Viral Therapy
Developmental Therapeutics – Experimental Therapeutics
Gynecologic Cancer
Patient and Survivor Care